CD274 and neoplasm: performed a meta-analysis and found PD-L1 overexpression was relevant to inferior tumor stage (OR= 0.57), vascular invasion-negativity (Odds Ratio (OR)= 0.75), shorter OS (HR= 1.47) and shorter recurrence-free survival (RFS)/DFS (HR= 1.47).